共 8 条
[1]
Association of fibrinogen, Creactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Danesh J,Collins R,Appleby P,et al. The Journal of The American Medical Association . 1998
[2]
Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study ( 4S ). Scandinavian Simvastatin Survival Study Group. The Lancet . 1994
[3]
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infaration. Hamsten A,Wimem B,De Faire U,et al. The New England Journal of Medicine . 1985
[4]
Antiatherothrombotic properties of statins:implications for cardiovascular event reduction. Rosenson RS,Tangney CC. The Journal of The American Medical Association . 1998
[5]
Fibrinolytic activity, clotting factors,and long-term incidence of ischaemic heart disease in the Northuick Park Heart Study. Meade TW,Ruddock V,Stirling Y,et al. The Lancet . 1993
[6]
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and systemic hemostatic profile. Dangas G,Badimon JJ,Smith DA,et al. Journal of the American College of Cardiology . 1999
[7]
Inhibition of thrombin gereration by simvastatin and lack of additive effect of aspirin in patients with marked hypercholesterolemia. Szczeklik A,Musial J,Undas A,et al. Journal of the American College of Cardiology . 1999
[8]
Platelet-dependent thrombin generation in patients with byperlipidaemia. Aoki I,Aoki N,Kawano K,et al. Journal of the American College of Cardiology . 1997